Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …
R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered …
U Zimmermann, G Gavazzi, P Richard, C Eymin… - Vaccine, 2013 - Elsevier
BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …
Combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults
E Grimprel, F Von Sonnenburg, R Sänger, V Abitbol… - Vaccine, 2005 - Elsevier
Many countries recommend diphtheria, tetanus and/or poliomyelitis boosters in adolescents
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria …
H Theeten, H Rümke, FJP Hoppener… - … medical research and …, 2007 - Taylor & Francis
Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …
[HTML][HTML] Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and …
M Kovac, N Rathi, S Kuriyakose, K Hardt, TF Schwarz - Vaccine, 2015 - Elsevier
Background Pertussis in adults and adolescents could be reduced by replacing traditional
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination
PB McIntyre, MA Burgess, A Egan, L Schuerman… - Vaccine, 2009 - Elsevier
At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history
S Larnaudie, N Guiso, C Baptiste, C Desaint… - Human …, 2010 - Taylor & Francis
This study was to assess the humoral immune response induced by a vaccination schedule
routinely used in France in 18-50 year old adults with unknown vaccination history. In this …
routinely used in France in 18-50 year old adults with unknown vaccination history. In this …
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial
J Beytout, O Launay, N Guiso, A Fiquet, M Baudin… - Human …, 2009 - Taylor & Francis
Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
相关搜索
- diphtheria tetanus antigen content
- acellular pertussis antigen content
- acellular pertussis polio vaccine
- pertussis vaccine tetanus diphtheria
- acellular pertussis immunogenicity and reactogenicity
- acellular pertussis booster dose
- diphtheria tetanus primary vaccination
- acellular pertussis dtpa ipv
- acellular pertussis healthy adults
- diphtheria tetanus dtpa ipv
- polio vaccine dtpa ipv
- polio vaccine antigen content
- polio vaccine booster vaccination
- off label tetanus diphtheria
- pertussis vaccine off label
- elderly population tetanus diphtheria